IberiaBank’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-8,802
Closed -$1.68M 303
2018
Q3
$1.68M Buy
8,802
+5,096
+138% +$936K 0.21% 117
2018
Q2
$618K Buy
3,706
+346
+10% +$55.5K 0.11% 162
2018
Q1
$565K Buy
3,360
+533
+19% +$89.4K 0.11% 160
2017
Q4
$462K Sell
2,827
-3,607
-56% -$647K 0.07% 173
2017
Q3
$1.32M Buy
6,434
+985
+18% +$229K 0.22% 121
2017
Q2
$1.32M Buy
5,449
+249
+5% +$58.5K 0.39% 86
2017
Q1
$1.24M Buy
5,200
+2,440
+88% +$568K 0.39% 84
2016
Q4
$580K Buy
2,760
+38
+1% +$7.87K 0.21% 90
2016
Q3
$627K Sell
2,722
-158
-5% -$38.6K 0.27% 72
2016
Q2
$666K Buy
2,880
+569
+25% +$131K 0.29% 72
2016
Q1
$619K Buy
2,311
+61
+3% +$17.5K 0.29% 71
2015
Q4
$703K Buy
2,250
+550
+32% +$164K 0.32% 72
2015
Q3
$462K Buy
+1,700
New +$522K 0.24% 85

Other funds holding AGN

IberiaBank's AGN Position: Q4 2018 in Review

IberiaBank sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 8,802 shares — an estimated $1.68M sold.

IberiaBank first reported a position in AGN in Q3 2015 and held it in 13 quarters. The position peaked at $1.68M in Q3 2018. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • IberiaBank reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • IberiaBank sold 8,802 Allergan plc shares in Q4 2018, an estimated $1.68M.
  • IberiaBank first reported a position in Allergan plc in Q3 2015 and held it in 13 quarters.
  • IberiaBank's Allergan plc position peaked at $1.68M in Q3 2018.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on IberiaBank's 13F filing for Q4 2018, filed 29 Jan 2019.